1 October 2026NewsRegulation & IndustryMarisa Woutersen

5 LSPN takeaways: What’s keeping Europe’s IP teams on their toes?

LSPN Europe made its Basel debut, and two days of conversations showed just how much is changing for life sciences professionals—both in how they work and what they are being asked to do. Marisa Woutersen tallies up the talking points.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Week Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Atif Choudhury at achoudhury@lifesciencesipreview.com 


More on this story

Regulation & Industry
13 October 2026   Potential reforms to post-employment restrictions and contractual notice periods could make it harder for brand owners to protect trade secrets and manage staff departures, prompting questions about how businesses can safeguard their interests.
Regulation & Industry
9 October 2026   As the AIPPI World Congress returned to Germany for the first time in nearly half a century, it heard calls for greater international cooperation and legal harmonisation, highlighting why diversity matters for the future of IP and brand owners.
Regulation & Industry
30 September 2026   The Third Circuit has upheld Thomson Reuters’ victory over Ross Intelligence in the first US appellate ruling on whether AI training can qualify as fair use. With the court’s reasoning still sealed, the case could have significant implications for AI developers using copyrighted content to build competing products.